Sanofi Market Cap 2006-2018 | SNY

Sanofi market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Sanofi market cap as of December 12, 2018 is $113.24B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $113.240B $39.599B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $394.655B 18.50
Pfizer (PFE) United States $262.879B 14.82
Merck (MRK) United States $210.330B 18.23
Novartis AG (NVS) Switzerland $203.580B 17.45
AbbVie (ABBV) United States $133.274B 11.83
Eli Lilly (LLY) United States $121.123B 21.29
Novo Nordisk (NVO) Denmark $112.427B 18.26
AstraZeneca (AZN) United Kingdom $98.555B 12.24
GlaxoSmithKline (GSK) United Kingdom $93.444B 12.56
Bristol-Myers Squibb (BMY) United States $87.225B 14.37